Immunovant, Inc. IMVT Preferred stock, shares designated as Series A Junior Participating Preferred Stock (in shares)
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ConvertiblePreferredStockSharesReservedForFutureIssuance.
The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s preferred stock, shares designated as series a junior participating preferred stock (in shares).
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s preferred stock, shares designated as series a junior participating preferred stock (in shares)?
- Immunovant, Inc. (IMVT) reported preferred stock, shares designated as series a junior participating preferred stock (in shares) of 10K in Q4 2025.
- How has Immunovant, Inc.'s preferred stock, shares designated as series a junior participating preferred stock (in shares) changed year-over-year?
- Immunovant, Inc.'s preferred stock, shares designated as series a junior participating preferred stock (in shares) decreased by 0.0% year-over-year, from 10K to 10K.
- What is the long-term trend for Immunovant, Inc.'s preferred stock, shares designated as series a junior participating preferred stock (in shares)?
- Over 4 years (2021 to 2025), Immunovant, Inc.'s preferred stock, shares designated as series a junior participating preferred stock (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from 10K to 10K.